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Abstract
d-alanine is a structural component of mycobacterial peptidoglycan. The primary route of d-alanine biosynthesis in eubacteria is the enantiomeric conversion from l-alanine, a reaction catalyzed by d-alanine racemase (Alr). Mycobacterium smegmatis alr insertion mutants are not dependent on d-alanine for growth and display a metabolic pattern consistent with an alternative pathway for d-alanine biosynthesis. In this study, we demonstrate that the M. smegmatis
alr insertion mutant TAM23 can synthesize d-alanine at lower levels than the parental strain. The insertional inactivation of the alr gene also decreases the intracellular survival of mutant strains within primary human monocyte-derived
macrophages. By complementation studies, we confirmed that the impairment of alr gene function is responsible for
this reduced survival. Inhibition of superoxide anion and nitric oxide formation in macrophages suppresses the differential survival. In contrast, for bacteria grown in broth, both strains had approximately the same susceptibility to hydrogen peroxide, acidified sodium nitrite, low pH and polymyxin B. In contrast, TAM23 exhibited increased resistance to
lysozyme. d-alanine supplementation considerably increased TAM23 viability in nutritionally deficient media and within
macrophages. These results suggest that nutrient deprivation in phagocytic cells combined with killing mediated by reactive intermediates underlies the decreased survival of alr mutants. This knowledge may be valuable in the construction of mycobacterial auxotrophic vaccine candidates.
Abbreviations: DCS, d-cycloserine; GPL, glycopeptidolipid; NM-l-Arg, N-methyl-l-arginine; OPA, o-phthaldialdehyde; RNI, reactive nitrogen intermediates; ROI, reactive oxygen intermediates; SOD, superoxide dismutase
Three supplementary figures follow the References for this paper; they show growth curves for M. smegmatis parental, alr mutant, and complemented strains grown in MADC-TW and minimal medium, with or without d-alanine supplementation, and the susceptibility of M. smegmatis to hydrogen peroxide and sodium nitrite.

Introduction
Mycobacteria display complex cell walls consisting of glycolipids and proteins linked to the mycolyl-arabinogalactan-peptidoglycan backbone (Brennan & Nikaido, 1995; McNeil & Brennan, 1991). This structure is a major determinant
of mycobacterial drug resistance and pathogenesis (Daffé
& Draper, 1998; Trias & Benz, 1994), and its biosynthesis is

highly conserved among different mycobacterial species
(Belanger & Inamine, 2000). Intracellular survival is an essential determinant of mycobacterial pathogenesis. To survive within phagocytic cells, mycobacteria must overcome
the bactericidal mechanisms of macrophages, including reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) and lysosomal enzymes (Armstrong &
Hart, 1975; Lowrie & Andrew, 1988; Sturgill-Koszycki et al.,
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1994). Studies on auxotrophic mutants have demonstrated
that nutritional status also plays a role in the intracellular
survival of mycobacteria within macrophages (De Voss et al.,
2000; Hondalus et al., 2000; Jackson et al., 1999).
Mycobacterium smegmatis, a fast-growing species of low
pathogenicity, displays a basal but measurable level of resistance to macrophage killing. Studies with this micro-organism have been conducted using a diverse array of macrophages (Jordao et al., 2008), including murine (Anes et
al., 2006; Kuehnel et al., 2001) and human (McGarvey et al.,
2004; Miller & Shinnick, 2000) cell lines, and tissue-derived
macrophages of murine (Kocincova et al., 2009; Singh et al.,
2008; Wagner et al., 2005) or human origin (Garg et al., 2006;
Lagier et al., 1998). M. smegmatis interaction with mouse
phagocytic cells results in generation of ROI and RNI, including nitric oxide (Anes et al., 2006). In vitro susceptibility of M. smegmatis to RNI is well documented (Yu et al.,
1999). In addition, expression of Mycobacterium tuberculosis
genes in M. smegmatis alters its resistance to macrophage
killing, and this effect has been widely used in the identification of mycobacterial genes involved in intracellular survival of pathogenic mycobacteria (Miller & Shinnick, 2000;
Singh et al., 2008). Since M. smegmatis has a high-efficiency
genetic transfer system and fast growth, it has been used
as an affordable model to study mycobacterial physiology,
including the effects of metabolic changes on intracellular
survival, gene expression and regulation, and this is especially meaningful for the study of highly conserved pathways (Caceres et al., 1997; Danilchanka et al., 2008; Garg et
al., 2006; Glover et al., 2007; Lagier et al., 1998; Posey et al.,
2006; Provvedi et al., 2008).
d-alanine is a structural component of mycobacterial
peptidoglycan (Strominger, 1962). d-alanine racemase catalyses the primary route of d-alanine biosynthesis in mycobacteria (Chacon et al., 2002). d-alanine is also present
in the core head group of glycopeptidolipids (GPLs) of
many mycobacterial species, with Mycobacterium xenopi
illustrating the only exception among those species analyzed (Brennan & Nikaido, 1995; Eckstein et al., 2003;
Etienne et al., 2005; Riviere & Puzo, 1991). Genetic analysis of the d-alanine branch of peptidoglycan biosynthesis in mycobacteria was first carried out in M. smegmatis, which possesses, as does M. tuberculosis, only one alr
gene (Caceres et al., 1997; Cole et al., 1998). We have demonstrated that d-alanine racemase insertion mutants (alr)
are not dependent on d-alanine for growth (Chacon et al.,
2002). These mutants also exhibit increased susceptibility
to the bactericidal agent d-cycloserine (DCS), a d-alanine
analogue used as a second-line drug in tuberculosis treatment. We hypothesized that disrupting d-alanine biosynthesis would also impair survival in macrophages, as a result of modifications in the cell envelope and/or nutrient
deprivation in phagocytic cells. In this study we determine the levels of d-alanine biosynthesis and the survival
of M. smegmatis parental and alr mutant strains under various extracellular conditions and in human monocyte-derived macrophages.
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Methods
Bacterial strains, plasmid vectors and growth conditions. Bacterial strains and vectors used in this study have been previously described (Chacon et al., 2002). Escherichia coli DH5α was grown as described elsewhere (Sambrook et al., 1989). M. smegmatis parental strain
mc2155 (Snapper et al., 1990), its derived alr mutant TAM23 (Chacon
et al., 2002), and their transformants with the integrating vectors
pYUB178 (Pascopella et al., 1994), pYUB412 (Pavelka & Jacobs, 1999)
and pTAMU3 (Chacon et al., 2002), were grown at 37 °C with shaking (200 r.p.m. with an Innova 4300, New Brunswick Scientific) to
OD600 ~1.0. Supplements for complete Middlebrook 7H9 (BBL Microbiology Systems) medium were 0.2% (v/v) glycerol (Sigma-Aldrich),
0.05% Tween 80 (Sigma-Aldrich) to prevent clumping, 0.01% cycloheximide (A.G. Scientific) to prevent fungal contamination, and ADC
[0.5% bovine fraction V albumin (Amresco), 0.01 M glucose (Acros),
and 0.015 M NaCl (MADC-TW)]. Broth minimal medium was prepared as previously described (Chacon et al., 2002). Generation times
were determined as described elsewhere (Miller, 1972). c.f.u. were estimated from optical density measurements using appropriate calibration curves. In addition, M. smegmatis c.f.u. were determined after
incubation at 37 °C on MADC agar (Tween 80 was omitted from all
solid media) or appropriately supplemented 7H9 basal medium prepared with 15 g Bacto agar l−1 (Difco Laboratories). d-alanine (SigmaAldrich) was added at 50 mM as necessary to broth cultures and agar
plates.
Analysis of amino acid intracellular pools. Steady-state levels of
intracellular amino acid pools were determined as previously described (Feng & Barletta, 2003). M. smegmatis strains mc2155 and
TAM23 were grown in 250 ml minimal medium with 21 mM glycerol (carbon source) and 5 mM NH4Cl (nitrogen source) to exponential phase (OD600 0.5–0.9), treated for 2 h with or without DCS
at 75 μg ml−1, harvested, washed and sonicated to prepare cellfree protein-free extracts as previously described (Chacon et al.,
2002). Protein was removed from the supernatant by serial passages through YM-10 and YM-3 Centricon concentrators (Millipore
Corporation). Determination of amino acids was performed at the
Amino Acid Geochronology Laboratory of Northern Arizona University (Flagstaff, AZ) by a reverse-phase HPLC procedure as described elsewhere (Kaufman & Manley, 1998). This procedure was
able to detect nine pairs of l- and d-amino acids in the subpicomolar range based on the derivatization reaction of amino acids with
o-phthaldialdehyde (OPA) and the chiral compound N-isobutyryll-cysteine. The synthetic amino acid l-homo-arginine (l-hArg) was
spiked in the samples at 10 μM as an internal standard. The total amount of amino acids in the recovered pools was averaged for
each strain/treatment combination and expressed as micromoles total OPA-derivatized product per 1 × 109 cells. Relative abundance
percentiles of individual amino acids were calculated as a molar
percentage of the total pool for each sample.
Intracellular killing assays. Intracellular killing assays were carried
out as described previously, with some modifications (Bermudez &
Young, 1988). Prior to infection, M. smegmatis cells were grown in
MADC-TW with and without d-alanine to OD ~1.0, harvested, and
resuspended in Hanks’ Balanced Salts Solution (HBSS; Sigma-Aldrich). Cells were passed through a membrane filter (1.2 μm poresize, Millipore) to obtain a single-cell suspension, and sedimented
for 5 min at room temperature. Macrophages were infected with
1.0 ml supernatant appropriately diluted in HBSS. Monocytes (1.0–
5.0×105 per well) derived from blood of healthy human donors were
seeded in tissue-culture plates (Sigma-Aldrich) and incubated for
2 h at 37 °C in 5% CO2. Procedures for blood collections were performed in compliance with all federal and local regulations. Supernatant fluids with non-adherent cells were removed and the wells
were washed twice with 1.0 ml prewarmed HBSS. The adherent
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monocytes were maintained in culture for 7 days with 1.5 ml complete RPMI 1640 (Invitrogen) medium supplemented with 2 mM lglutamine (Sigma-Aldrich) and 10% heat-inactivated fetal bovine serum (Sigma-Aldrich), and d-alanine where indicated; the medium
was replaced every 48 h.
Macrophage monolayers were infected at an m.o.i. of 1 or 10 bacilli
per cell, as indicated. Monolayers were incubated for 1–2 h at 37 °C in
5% CO2 followed by three washes with HBSS to remove extracellular
micro-organisms. Similar washes were performed at each time point.
An m.o.i. of 1 bacillus per cell was used as necessary to maximize the
effects of host cell restriction on bacterial growth. For inhibitor treatment assays, cells were split 30 min post-infection and supplemented
as indicated with bovine superoxide dismutase (SOD; Sigma-Aldrich), human catalase (Sigma-Aldrich), or the nitric oxide (NO) synthase inhibitor N-methyl-l-arginine (NM-l-Arg; Sigma-Aldrich) following previously described procedures (Bermudez & Young, 1989;
Bermudez, 1993). Cells were lysed at 1 or 2, 24, 48 (except inhibitor
assays) and 72 h with 0.5 ml sterile double-distilled H2O (ddH2O) for
10 min and 0.025% SDS (Sigma-Aldrich) in HBSS for another 10 min.
SDS was subsequently removed with 0.1% bovine albumin and the
lysate was plated on MADC. Three replicate wells were used per experimental group, in at least two independent experiments.
Cell viability was determined by trypan blue exclusion as previously described (Bermudez & Young, 1988). The viability of the
cell monolayer post-infection decreased slightly from 98–99% (1 h)
to 90–92% (24 h), 84–86% (48 h) and 73–77% (72 h). No significant
differences were observed at each time point in the viability of macrophage monolayers subjected to different treatments or infected
with various strains. To verify that the addition of SDS did not detrimentally affect the viability of the M. smegmatis parental and alr
mutant strains, ~5.0×106 c.f.u. were treated with ddH2O for 10 min
and 0.025% SDS for 10 min, and 0.1% albumin was added. Bacteria
were plated to determine c.f.u. There were no significant differences
for the titer of either mc2155 (P = 0.7662) or TAM23 (P = 0.6901)
strains before and after treatment, or between mc2155 and TAM23
(P = 0.9422) in their susceptibility to SDS. Another experiment using
20 μg amikacin ml−1 (Sigma-Aldrich) during invasion yielded similar results, demonstrating the effectiveness of the washing procedure for removing extracellular bacteria (data not shown).
Susceptibility assays. Susceptibility assays with M. smegmatis cells
grown in MADC-TW were carried out at different treatment agent
levels (hydrogen peroxide, lysozyme and polymyxin B sulfate) or the
kinetics of killing was followed at a standardized level of the agent
(sodium nitrite, hydrochloric acid and lysozyme). The effect of hydrogen peroxide (H2O2) on the viability of M. smegmatis was determined
as described elsewhere (Yu et al., 1998). Cell cultures were grown with
or without d-alanine, harvested, washed with PBS-Tween 80 (PBSTW), resuspended in the same volume of PBS-TW, and treated with
0–30 mM H2O2 (Sigma-Aldrich) in 5 mM increments. Cells were incubated for 30 min at 37 °C, washed with MADC-TW, and plated on
MADC supplemented with d-alanine. To determine the effects of lysozyme, cells were plated on MADC with 0, 500, 750 and 1000 μg ml−1
of hen egg-white lysozyme (Sigma-Aldrich). To determine the susceptibility to the model antimicrobial cationic peptide polymyxin B
(sulfate salt, Invitrogen), bacteria were plated on MADC with 0, 16,
32, 64 and 96 μg ml−1 of this antimicrobial peptide.
Sodium nitrite (NaNO2) susceptibility was determined as previously described (Firmani & Riley, 2002), with modifications. Cell aliquots (0.5 ml) were adjusted to ~1.0×106 c.f.u. ml−1 and added to
MADC-TW at pH 4.0 or 6.5 adjusted with HCl and 0, 2, 4 or 6 mM
NaNO2 (Sigma-Aldrich). Samples were collected at 0, 2, 5 and 24 h
post-treatment. For susceptibility to HCl alone, 0.5 ml cell aliquots
(adjusted to ~1.0×108 c.f.u. ml−1) were combined with MADC-TW at
pH 4.0 adjusted with HCl. Samples were taken at 0, 7, 12, 24, 48, 72
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and 96 h after treatment. To follow the kinetics of lysozyme, cells were
grown in MADC-TW with or without 500 μg lysozyme ml−1. Samples
were collected at 0, 3, 6, 12 and 24 h post-treatment and washed with
MADC-TW. In all cases, c.f.u. were determined on MADC agar.
MICs were determined by a previously described microdilution
method (Chacon et al., 2002). Two compounds were tested: imipenem (compound MK0787, US Pharmacopeia), a β-lactam transpeptidase inhibitor with broad-spectrum anti-microbial activity (Kesado et
al., 1980); and vancomycin (Sigma-Aldrich), a glycopeptide that binds
to d-alanyl-d-alanine moieties (Perkins & Nieto, 1974). Briefly, cells
were grown in MADC-TW to mid-exponential phase (OD600 0.6–1.0),
adjusted to ~1.0×105 c.f.u. in 0.1 ml, and inoculated into 96-well microplates containing serial twofold dilutions of the corresponding antimicrobial agent. The MIC was defined as the minimal drug concentration that prevented visible bacterial growth at 37 °C after 48 h.
Effects of nutritional supplements on M. smegmatis growth.
Strains mc2155 and TAM23 were grown in MADC-TW without and
with d-alanine, respectively. Bacteria were washed twice with PBSTW, resuspended in the original volume of PBS-TW, and plated
on 7H9 basal agar without and with supplementation with 0.15%
(v/v) glycerol; 50 mM d-alanine; 0.5% (w/v) albumin; 10 mM glucose; albumin, glucose and d-alanine; or glycerol, ADC and d-alanine (MADC+d-alanine).
Statistical and graphical analysis. Statistical analyses were performed using SAS version 9.1.3, 2004 (SAS Institute). Log-transformed c.f.u. were analyzed as a repeated measure design and included the effects for strain and treatment, and their interaction.
The repeated measures analyses were carried out using the Mixed
procedure. The covariance structure for each analysis was selected
based on the Schwarz’s Bayesian Criterion. Post-hoc comparisons
for the amino acid analysis were carried out using Tukey adjusted P
values; for the nutritional supplement analysis, Bonferroni adjusted
P values were used. The Cluster procedure was used to determine
the average linkage distance (joins clusters with small variances) between strains grouped together. For the H2O2, lysozyme and polymyxin B analyses, LD50 values were estimated for each strain replicate combination using the Probit procedure. These LD50 values
were then analyzed as a one-way ANOVA. Contrast and estimate
statements were used to determine the statistical significance for
line graphs. Bar and line graphs were constructed using DeltaGraph
version 5.6.2 (Red Rock Software).

Results
Extracellular growth of M. smegmatis strains in broth
with and without d-alanine
Extracellular growth of M. smegmatis strains was evaluated in broth media. In MADC-TW (with glycerol, l-glutamate and ammonium chloride as carbon and nitrogen
sources), mc2155 started growing immediately with a
generation time of 165 ±23 min, reaching a maximum at
OD600 3.2 (Supplementary Figure S1a). When d-alanine
was added, the mc2155 generation time was longer (195
±27 min), reaching an upper limit at OD600 1.7. TAM23
grew with about the same generation time in MADC-TW
with (225 ±32 min) and without (210 ±30 min) d-alanine.
Both values were greater than those for mc2155 (Supplementary Figure S1b). However, the yield was higher with
d-alanine than in its absence, as OD600 values were 2.6 and
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1.4, respectively. In addition, growth in the absence of dalanine was characterized by a lag time of 30 ±4 h that did
not occur with d-alanine. Complementation of TAM23
with the integrating vector pTAMU3, which carries the
wild-type alr gene, restored parental properties. The generation times of TAM23 (pTAMU3) in the presence and
absence, of d-alanine were 210 ±30 and 180 ±25 min, respectively. More importantly, this recombinant strain
grew in the absence of d-alanine without a lag time (Supplementary Figure S1c), reaching OD600 3.0, similar to
the wild-type strain. As expected in the presence of d-alanine, TAM23(pTAMU3) reached a lower OD600 value of
2.1. Growth patterns were also determined in nutrientrestricted minimal medium with glycerol (sole carbon
source) and ammonium chloride (sole nitrogen source).
Similar results were obtained for the parental and complemented strains, but TAM23 grew with longer generation and lag times in the absence of d-alanine (Supplementary Figure S2). A second passage of TAM23 without
d-alanine resulted in a growth pattern similar to that of
mc2155, displaying no lag time (Chacon et al., 2002).
Biosynthesis of d-alanine in an M. smegmatis alr insertion mutant
The d-alanine-independent phenotype of M. smegmatis alr
insertion mutants suggests that M. smegmatis possesses an
alternative pathway of d-alanine biosynthesis (Chacon et
al., 2002; Halouska et al., 2007). Alternatively, this micro-organism may be able to synthesize peptidoglycan and other
essential components without d-alanine. To distinguish between these two alternative hypotheses, we determined
whether the mutant strain could synthesize d-alanine.
Strains mc2155, mc2155 treated with the Alr inhibitor
DCS, and TAM23 synthesized approximately the same
level of total amino acids, as quantified by OPA (Figure 1,
inset). This result demonstrates that bacteria do not compensate for the alr mutation by making more of all amino
acids. However, significant changes in their relative abundance were observed (Figure 1). When compared with
untreated mc2155, mc2155 with DCS (P = 0.0061) and
TAM23 (P = 0.0005) yielded a 14 and 25% decrease in the
highly abundant l-glutamate-l-glutamine (l-Glx) pool, respectively. This result is consistent with the decrease in
the overall glutamate pool observed in our TAM23 metabolomic analysis (Halouska et al., 2007). Significant increases were observed in the l-alanine (l-Ala) pools for
TAM23 (about 4.5-fold, P < 0.0001) and mc2155 with DCS
(about 1.7-fold, P = 0.0003) compared to mc2155. A decreasing trend was detected in the d-alanine (d-Ala) pools
upon treatment with DCS or in TAM23. These results
further confirm our metabolomic studies, but the current analysis shows that the total increase in the alanine
pools is determined by higher levels of the l-enantiomer.
Though not significant at the P < 0.05 level, similar trends
were seen for the total l(d)-aspartate-l(d)-asparagine
(l-Aspx/d-Aspx) pools.

Figure 1. Intracellular M. smegmatis steady-state amino acid pools.
Standard amino acid nomenclature is used and results are reported
as mean ±sem, n = 2–4. Symbols: striped bars, mc2155 without DCS;
white bars, mc2155 with DCS; black bars, TAM23 without DCS. Inset: the total amino acid pool (total OPA-derivatized product) recovered from 1×109 cells. Statistical significance is indicated as follows:
*P = 0.01–0.05; **P = 0.001–0.01; ***P < 0.001. Pairwise determinations are displayed as follows: the upper left compares mc2155 without
DCS to mc2155 with DCS, the upper right compares mc2155 with DCS
to TAM23, and the lower middle compares mc2155 to TAM23. All other
comparisons were not significant (P > 0.05).

In all cases, mc2155 with DCS followed the same trend
as TAM23, but TAM23 displayed the most extreme values, as expected from the complete inactivation of the alr
gene, in contrast to the DCS inhibition of Alr enzyme activity. Importantly, the internal d-Ala pools, although approximately 3.5-fold less than those of mc2155, were above
background levels. Thus, inhibition of the Alr enzyme by
DCS or impairment of alr gene function has a significant influence on alanine metabolism, leading to a decrease in the
d-Ala pool and an accumulation of l-Ala. The l-Ala:d-Ala
ratio was 1.7:1 for mc2155, 10:1 for mc2155 with DCS, and
28:1 for TAM23.
M. smegmatis alr mutants display impaired survival in
human macrophages
Since alr insertion mutants displayed poor growth in media without d-alanine, we hypothesized that d-alanine limitation would also lead to decreased intracellular survival
in the nutrient-limiting macrophage environment. To max-
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imize potential differences, macrophage monolayers were
infected with bacilli grown in medium without d-alanine.
The uptake levels at 2 h post-infection for both parental
and mutant strains were similar (Figure 2). As expected,
mc2155 displayed moderate survival in macrophages,
while TAM23 survived very poorly (P < 0.0001). The complemented strain TAM23 (pTAMU3) displayed similar
survival levels at 48 h (P = 0.3867) and 72 h (P = 0.2473)
compared with mc2155. This result confirmed that the inactivation of the alr gene is responsible for the reduced intracellular survival of TAM23.
In addition, we tested the effects of selection markers on
the survival of M. smegmatis in phagocytic cells (Figure 2).
Strain mc2155 (pYUB178), which carries the kanamycin-resistance marker used to inactivate the alr gene, displayed a
survival trend similar to that of the parental strain at 48 h
(P = 0.3475), indicating that this marker does not affect
the intracellular survival of M. smegmatis. Strain mc2155
(pYUB412), which carries the hygromycin-resistance complementing vector, displayed an increase in intracellular survival at all time points as compared with TAM23 (P
< 0.0001). At 24 h post-infection, TAM23 (pYUB412) displayed a similar fivefold reduction in intracellular survival as seen for TAM23; however, at 48 and 72 h, TAM23
(pYUB412) displayed an intermediate level of survival
when compared with mc2155 and TAM23. Thus, the hygromycin-resistance marker influences intracellular survival at longer times post-infection. Nonetheless, the effect
is different from the complete recovery of TAM23 survival
conferred, at every time point post-infection, by the hygromycin-resistance integrating vector pTAMU3 carrying the

Figure 2. Intracellular survival of M. smegmatis in human macrophages. Monolayers were infected at an m.o.i. of 10 bacilli per cell with
mc2155 (●), TAM23 (■), TAM23 (pTAMU3) (▲), TAM23 (pYUB412)
(▼) or mc2155 (pYUB178) () grown in Middlebrook media without dalanine. Results are reported as mean ±sem, n = 3, with statistical significance indicated as ***, P < 0.001.

O. Chacon et al. in Microbiology 155 (2009)

wild-type alr gene. In summary, global analysis of survival
data indicated that each strain displayed a unique survival curve (P < 0.0001). However, cluster analysis grouped
mc2155, TAM23 (pTAMU3) and mc2155 (pYUB178) together with a normalized root mean square distance
(NRMSD) of 0.27. This cluster was separated from the
TAM23 (pYUB412) (NRMSD = 0.73) and TAM23 (NRMSD
= 1.43) clusters. Thus, the inactivation of the alr gene has a
significant effect on the ability of M. smegmatis to survive
within phagocytic cells (P < 0.0001).
Susceptibility of M. smegmatis to bactericidal agents
Experiments were performed to further define the susceptibilities of wild-type and alr mutant strains to agents
that mediate or enhance intracellular bactericidal action in macrophages. Susceptibilities to reactive intermediates were first assessed on bacteria grown in broth by
determining the effects of H2O2 and acidified NaNO2. As
shown in Supplementary Figure S3(a), no significant differences were observed in the susceptibilities to H2O2 (P
= 0.0544) of mc2155 without d-alanine (LD50 9.73%, v/v),
mc2155 with d-alanine (LD50 9.57%, v/v), TAM23 without d-alanine (LD50 13.34%, v/v) and TAM23 with d-alanine (LD50 9.10%, v/v). Likewise, no significant differences were observed between mc2155 and TAM23 treated
and not treated with NaNO2 (P = 0.1198) over a 24 h period (Supplementary Figure S3b).
Susceptibilities to ROI and RNI within macrophages
were also tested using inhibitors (Figure 3). Treatment of
monolayers with the H2O2-detoxifying enzyme catalase did
not result in significant differences for mc2155 (P = 0.1544)
or TAM23 (P = 0.6225) as compared with the corresponding
untreated controls, while major differences were observed
between strains (P = 0.0002). Scavenging of superoxide anion with SOD led to significant differences for TAM23 (P
< 0.0001) as compared with the untreated control, while a
minor effect was observed for mc2155 (P = 0.1316 comparing all time points, P = 0.0158 at 72 h). However, no significant differences were observed between strains upon SOD
treatment (P = 0.6116). Inhibition of NO synthase with NMl-Arg resulted in a significant increase in the survival of
mc2155 (P = 0.0238) and TAM23 (P < 0.0001) as compared
with the corresponding untreated controls, with no difference between the strains (P = 0.9171), indicating that production of reactive intermediates plays an important role
in differential killing.
Upon phagolysosomal fusion, mycobacteria may be exposed to acid pH, lysosomal enzymes and cationic peptides. Exposure of mc2155 and TAM23 to pH 4.0 (without
NaNO2) for 24 h did not result in significant differences
(Supplementary Figure S3b). Furthermore, extending the
pH treatment to 96 h yielded the same outcome (data not
shown). The potential effects of the alr mutation on the
peptidoglycan structure may result in altered susceptibil-
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Figure 3. Effect of reactive intermediate inhibitors on the intracellular survival of M. smegmatis in human macrophages. Monolayers were infected at an m.o.i. of 1 bacillus per cell with either mc2155
(●) or TAM23 (■) grown in Middlebrook medium without d-alanine. After 30 min, cells were split and either not treated (unbroken lines) or
treated with SOD (dashed–dotted lines), catalase (dashed lines) or
NM-l-Arg (nearly overlapping; dotted lines). Results are reported as
mean ±sem, n = 2.

ity to lysozyme and polymyxin B. Treatment with 500 or
750 μg lysozyme ml−1 decreased survival of mc2155 (~95%)
and TAM23 (~85%) (P = 0.0344), with a more pronounced
effect (~98% for both strains) at 1000 μg lysozyme ml−1
(Figure 4a). Significant differences were observed in the
susceptibilities to lysozyme of mc2155 (LD50 47 μg ml−1)
and TAM23 (LD50 205 μg ml−1). To confirm these results,
the bactericidal action of 500 μg lysozyme ml−1 was also
followed in MADC-TW 24 h post-treatment (Figure 4b).
The survival dropped 500- (TAM23) to 4500-fold (mc2155),
indicating that lysozyme has a greater bactericidal action
on the parental strain (P < 0.0001), although the survival
curves follow similar trends. Thus, the changes in TAM23
appear to make its peptidoglycan less susceptible to lysozyme. In contrast, TAM23 was slightly more susceptible to
polymyxin B than mc2155 (Figure 4c), although this trend
did not reach statistical significance (P = 0.0660).
We have reported the hypersusceptibility of TAM23
to DCS with an MIC of 2.56 μg ml−1, as compared with
75 μg ml−1 for mc2155, while the susceptibilities to amikacin, ethambutol and ribafutin remain at parental levels
(Chacon et al., 2002). In this study, the MICs against two
additional drugs related to peptidoglycan structure were
determined. Mutant TAM23 was significantly more susceptible to imipenem (MIC 0.625 versus 20 μg ml−1) and
vancomycin (MIC 1.56 versus 12.5 μg ml−1). These results
are consistent with peptidoglycan alterations as a result of
the downshift in the d-alanine pool.

Figure 4. Susceptibility of M. smegmatis to lysozyme and polymyxin
B. For lysozyme assays, cells were plated at various concentrations
(a) or treated with 500 μg ml−1 for different time periods (b). For polymyxin B assays (c), cells were plated at various concentrations. Symbols and line patterns are: ●, mc2155; ■, TAM23; ——, mc2155 and
TAM23 with lysozyme; ∙∙∙∙∙∙∙∙, mc2155 and TAM23 without lysozyme.
Results are reported as mean ±sem, n = 3, with statistical significance
displayed as NS, not significant (P > 0.05); *, P = 0.01–0.05; **, P =
0.001–0.01; ***, P < 0.001.
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Table 1. M. smegmatis cell viability on Middlebrook 7H9 basal agar
with and without supplementation
Supplementation

None

Mean log(c.f.u.)*		
mc2155

TAM23

3.67

0.60

P value†

<0.0001

Glycerol (0.15 %, v/v)

4.91

4.29

<0.0001

d-Alanine

4.92

3.74

<0.0001

4.80

4.57

0.2435

(50 mM)

Albumin (0.5 %, w/v)
Glucose (10 mM)

4.96

4.79

0.6492

Albumin + glucose + d-alanine

5.77

5.71

0.9999

Glycerol + ADC + d-alanine
(MADC + d-alanine)

5.78

5.76

1.0000

*Strains mc2155 (without 50 mM d-alanine) and TAM23 (with 50 mM dalanine) were grown at 37 °C in MADC-TW to OD600 ~1.0, washed
twice in PBS-TW, and plated on solid media (SEM = 0.056, n = 3).
† Bonferroni adjustment (significant at P < 0.007).

Effect of nutritional supplements on M. smegmatis
growth
Macrophages restrict nutrients to phagocytosed bacteria, an effect that has been termed a nutriprive mechanism (Appelberg, 2006). This restriction may include essential ions (Wagner et al., 2005), purines, pyrimidines, amino
acids and vitamins. To test the effects of nutritional supplementation, parental and mutant cells were plated on
various solid media. As shown in Table 1, significant differences were found between mc2155 and TAM23 on 7H9
basal medium and 7H9 supplemented with glycerol or dalanine. No significant differences were observed for the
remaining supplementations. Comparing the growth performance of each strain individually in the various media,
both strains performed best and equally well on basal agar
with albumin, glucose and d-alanine; and MADC plus dalanine (P = 1.00). Intermediate growth was observed for
both strains with the addition of glycerol, d-alanine, albumin or glucose to the basal medium. Basal agar yielded the
poorest growth for both strains with a more prominent effect on TAM23. These observations confirmed that alr insertional mutants grow better with d-alanine, but are not
dependent on this nutrient.
To test for the effect of d-alanine in macrophages, parental and mutant strains were grown in MADC with
or without d-alanine prior to the infection of monolayers cultured without d-alanine. The uptake of mc2155
and TAM23 by monolayers of adherent human macrophages 1 h post-infection was similar, regardless of d-alanine supplementation (Figure 5a). As expected, mc2155
grown in broth with or without d-alanine displayed similar survival in macrophages (P = 0.309), but TAM23 survived better when grown in broth with d-alanine (P <
0.0001). As described above (Figure 2), mc2155 survived

better than TAM23 (P < 0.0001, for all pairwise comparisons). A similar effect was obtained when TAM23 was
grown without d-alanine and macrophage monolayers were incubated with or without d-alanine during the
course of the infection (Figure 5b). In the absence of d-alanine, TAM23 was less able to survive as compared with
conditions in which monolayers were supplemented with
d-alanine (P = 0.0166). In summary, the difference in the
viability of both strains in basal media reflected the intracellular survival data well.

Discussion
The goal of this study was to analyze the physiological consequences of the insertional inactivation of the alr gene in
M. smegmatis in the context of both extracellular and intracellular survival. We have shown that alr insertion mutants
are not dependent on d-alanine for growth, and display
changes in colony morphology, metabolomic profiling and
hypersusceptibility to DCS (Chacon et al., 2002; Halouska
et al., 2007). We hypothesized that alr mutants synthesize
d-alanine by an alternative pathway. In contrast, another
study indicates that M. smegmatis alr deletion mutants are
auxotrophic for d-alanine (Milligan et al., 2007). However,
there are significant differences in the experimental design
that led to mutant isolation and characterization in the two
studies, including a two-step procedure and shorter follow-up incubation in the study of the alr deletion mutants.
Furthermore, metabolomic analysis of the TAM23 alr insertion mutant indicates metabolic changes more readily
compatible with the activation of an alternative pathway of
d-alanine biosynthesis (Halouska et al., 2007). Thus, the differences between these two studies may reflect changes in
the experimental conditions.
In this study, the analysis of the amino acid pools indicates that the TAM23 alr mutant exhibits lower, but above
background, levels of d-alanine and l-glutamate and accumulation of l-alanine, as compared with the parental
strain. These results are consistent with our hypothesis
and previous studies (Chacon et al., 2002; Halouska et al.,
2007). As expected, the effect of alr insertional inactivation on these amino acid pools is more pronounced than
the effect of DCS, an Alr inhibitor. Thus, insertional inactivation of the alr gene in TAM23 results in markedly reduced availability of d-alanine (indicated by a low d-alanine pool in the mutant), possibly leading to decreased
incorporation of this amino acid into peptidoglycan and
glycolipids. Structural analyses will be conducted to test
this hypothesis.
The insertional inactivation of the M. smegmatis alr gene
resulted in 80% reduction in the intracellular survival of
the mutant strain in monocyte-derived human macrophages at 24 h post-infection (Figure 2). This effect is considerably more pronounced than the 20–50% reduction
observed for other M. smegmatis mutants under similar
conditions (Lagier et al., 1998). The conservation of basic
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Figure 5. Effect of d-alanine on the intracellular survival of M. smegmatis in human macrophages. Monolayers were infected at an m.o.i. of 1 bacillus per cell with either mc2155 (●) or TAM23 (■) grown in Middlebrook media. (a) Bacilli were grown in broth with (dashed lines) or without (unbroken lines) d-alanine. (b) Bacilli were grown in broth without d-alanine and macrophage monolayers were incubated with (dashed lines) or without (unbroken lines) d-alanine. Results are reported as mean ±sem, n = 3, with statistical significance displayed as NS, not significant (P > 0.05);
*, P = 0.01–0.05; ***, P < 0.001.

metabolic pathways in mycobacteria plus the effect of alr
mutation on extracellular and intracellular survival of M.
smegmatis would predict a considerable degree of attenuation for alr mutant strains of pathogenic mycobacterial species, provided viable mutants could be obtained.
Pathogenic mycobacteria have greater ability to evade
bactericidal mechanisms such as phagosome acidification, while M. smegmatis fails to prevent this process (Sturgill-Koszycki et al., 1994). However, intracellular bacilli of
both M. smegmatis and pathogenic mycobacterial species
are exposed to killing by reactive intermediates (Anes et al.,
2006; Jordao et al., 2008; Nathan & Shiloh, 2000; Shiloh &
Nathan, 2000), though controversial results have been obtained (Ehrt et al., 1997). In our case, extracellular treatment
with H2O2, NaNO2 and acidic pH had a bactericidal action
on M. smegmatis, but did not reveal any major survival differences between the strains. H2O2 scavenging by catalase
treatment of infected monolayers had no effect on the viability of any of the strains as compared with untreated controls. However, scavenging of superoxide anion by SOD or
inhibition of NO synthase by the specific inhibitor NM-lArg resulted in decreased bactericidal activities in macrophage monolayers. This effect was more pronounced in the
alr mutant. This suggests that in our experimental conditions, reactive intermediates have an important role in M.
smegmatis killing by human macrophages, as indicated in
Figure 3. Since RNI inhibition may not affect superoxide
anion production by the phagocyte oxidase pathway, it is
possible that SOD scavenging of superoxide only limits its
conversion to peroxynitrite, a highly bactericidal product
formed from superoxide and NO. In contrast, other stud-

ies have failed to detect reactive intermediates and conclude that these molecules do not have a major role in M.
smegmatis killing by human monocytes (Jordao et al., 2008).
However, these molecules are difficult to detect, given their
short life and low concentrations in the macrophages (Forman & Torres, 2001; Valko et al., 2007).
The results presented herein suggest that the use of inhibitors is a more reliable indicator of the involvement of
reactive intermediates than the failure to detect relatively
low levels of these molecules by the Griess reaction. This
situation is particularly critical in our study, since the human monocytes were not activated with γ-interferon.
Nonetheless, infection with M. smegmatis (Ehrt et al., 1997),
maturation in culture (Martin & Edwards, 1993), and specific experimental conditions may sufficiently increase reactive intermediate levels, especially for RNI, to have bactericidal action on this micro-organism, as suggested by
our inhibition studies. Activation of the arginase pathway
reduces arginine availability for the NO synthase reaction
in murine macrophages (Martin et al., 2006). This leads to
an increase in intracellular levels of l-glutamate. A similar
effect might be possible upon NO synthase inhibition by
NM-l-Arg. Since l-glutamate seems to be involved in the
alternative pathway of d-alanine biosynthesis in M. smegmatis alr mutants, this effect could increase the survival of
the mutant strain to wild-type levels in the absence of dalanine (Figure 5). The differential microbicidal effect on
TAM23 in untreated macrophages may also reflect the increased permeability of the mutant strain to reactive intermediates. In either case, preloading of TAM23 cells with
d-alanine or its addition to monolayers had a partially com-
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pensatory effect (Figure 5). Thus, the effects of nutrient deprivation in phagocytic cells combined with killing mediated by reactive intermediates determined the differential
survival of the strains. The decreased pool of d-alanine
might also result in a further reduction in the GPL content
of TAM23, affecting both colony morphology and susceptibility to macrophage killing (Kocincova et al., 2009).
Additional bactericidal mechanisms operate in lysosomal compartments. In this context, we observed a slight
decrease rather than an increased susceptibility to lysozyme, an enzyme that hydrolyses the longitudinal peptidoglycan strands. This effect may be due to subtle changes
in the peptidoglycan layer. However, a weakened cell wall
structure was suggested by an increased susceptibility
to DCS (Chacon et al., 2002), imipenem, polymyxin B and
vancomycin. These findings are consistent with peptidoglycan alterations as a result of the downshift in the d-alanine pool.
Auxotrophic mutations decrease the intracellular survival of pathogenic micro-organisms, including mycobacteria (Appelberg, 2006; Crawford et al., 1996; Guleria et al.,
1996; Mintz et al., 1988). This effect may be related to the
reduced availability of nutrients in the phagosome, in contrast to the relatively rich cytoplasmic compartment. In the
case of mycobacteria, the vacuole is deficient in purines,
amino acids, vitamins and other nutrients (Brown et al.,
2005; Hondalus et al., 2000; Jackson et al., 1999; Pavelka et
al., 2003). Our studies suggest a combined effect of nutrient deficiency and reactive intermediate molecules on the
intracellular survival of mycobacteria inside nutrient-deficient vacuoles. Inhibition of ROI and/or RNI may also result in metabolic changes in the phagosome that could alter the attenuation of auxotrophic mutant strains. Mutants
absolutely dependent on d-alanine for growth would likely
autolyse in vivo, providing potentially safer auxotrophic
vaccines. If the alr gene is essential in M. tuberculosis, as
suggested by global genomic analysis (Sassetti et al., 2003),
it may still be possible to engineer viable mutants by introducing the M. smegmatis alternative pathway genes under the control of a regulated promoter. Thus, these studies
are significant for the development of novel live attenuated
vaccines to control mycobacterial diseases.
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Supplementary Figures

Supplementary Figure S1. Growth curves of M. smegmatis parental, alr mutant and complemented strains in Middlebrook medium.
Strains mc2155 (a), TAM23 (b), and TAM23 (pTAMU3) (c) were grown in MADC-TW with d-alanine. Cells were harvested, washed
twice with PBS-TW, and inoculated 1:50 into MADC-TW. Growth (OD600) was recorded for 95 h. Symbols indicate growth with (open
symbols) or without (filled symbols) d-alanine supplementation.
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Supplementary Figure S2. Growth curves of M. smegmatis parental, alr mutant, and complemented strains in minimal medium.
Strains mc2155 (a), TAM23 (b), and TAM23 (pTAMU3) (c) were grown in MADC-TW with d-alanine. Cells were harvested, washed
twice with PBS-TW, and inoculated 1:50 into minimal medium. Growth (OD600) was recorded for 95 h for all strains except TAM23
which was grown for 115 h. Symbols indicate growth with (open symbols) or without (filled symbols) d-alanine supplementation.

Supplementary Figure S3. Susceptibility of M. smegmatis to reactive-intermediate-generating compounds. For H2O2 assays (a),
cells were treated with increasing concentrations for 30 min and plated. For NaNO2 assays (b), cells were treated at pH 4.0 with
or without 2 mM NaNO2 as these conditions yielded significant overnight killing. Symbols and line patterns are ●, mc2155 without
d-alanine; ■, TAM23 without d-alanine; ○, mc2155 with d-alanine; □, TAM23 with d-alanine; unbroken lines, mc2155 and TAM23
with NaNO2; and dashed lines, mc2155 and TAM23 without NaNO2. Results are reported as means ±SEM, n = 3, with statistical
significance displayed as NS, not significant (P > 0.05).

